loading

Rhythm Pharmaceuticals Inc Aktie (RYTM) Neueste Nachrichten

pulisher
03:14 AM

Bank of New York Mellon Corp Sells 680 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

03:14 AM
pulisher
Mar 14, 2025

Insider Sell Alert: EVP, Head of North America Jennifer Lee Sells Shares of Rhythm Pharmaceuticals Inc (RYTM) - GuruFocus.com

Mar 14, 2025
pulisher
Mar 12, 2025

How To Trade (RYTM) - Stock Traders Daily

Mar 12, 2025
pulisher
Mar 12, 2025

SBI Securities Co. Ltd. Invests $37,000 in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Stifel maintains Buy on Rhythm Pharmaceuticals, $78 target By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 10, 2025

Reviewing Wave Life Sciences (NASDAQ:WVE) & Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Rhythm Pharmaceuticals (NASDAQ:RYTM) Earns Overweight Rating from Morgan Stanley - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Assessing Rhythm Pharmaceuticals: Insights From 10 Financial Analysts - Benzinga

Mar 07, 2025
pulisher
Mar 07, 2025

Promising Outlook for Rhythm Pharmaceuticals: Buy Rating Backed by Positive Phase 3 Study Expectations and Market Potential - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Stifel Nicolaus Begins Coverage on Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Analysts Set Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) PT at $68.27 - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Citizens JMP maintains Rhythm Pharma Outperform, $81 target By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

HC Wainwright Brokers Raise Earnings Estimates for RYTM - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Citizens JMP maintains Rhythm Pharma Outperform, $81 target - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Principal Financial Group Inc. Purchases 4,298 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Brokers Issue Forecasts for RYTM FY2026 Earnings - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

Promising Market Potential for Rhythm Pharmaceuticals’ Setmelanotide in Treating Hypothalamic Obesity - TipRanks

Mar 06, 2025
pulisher
Mar 05, 2025

Stifel raises Rhythm Pharmaceuticals stock to Buy with $78 target By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

US High Growth Tech Stocks to Watch in March 2025 - Yahoo Finance

Mar 05, 2025
pulisher
Mar 04, 2025

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

Y Intercept Hong Kong Ltd Invests $328,000 in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

HC Wainwright Issues Positive Forecast for Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Rhythm Pharmaceuticals Faces Financial Risks Due to Convertible Preferred Stock Prioritization - MSN

Mar 03, 2025
pulisher
Mar 03, 2025

Rhythm Pharmaceuticals stock target raised to $70 at H.C. Wainwright - Investing.com India

Mar 03, 2025
pulisher
Mar 01, 2025

Learn to Evaluate (RYTM) using the Charts - Stock Traders Daily

Mar 01, 2025
pulisher
Mar 01, 2025

Decoding Rhythm Pharmaceuticals Inc (RYTM): A Strategic SWOT Ins - GuruFocus.com

Mar 01, 2025
pulisher
Mar 01, 2025

Needham & Company LLC Reaffirms “Buy” Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM) - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Rhythm Pharmaceuticals (NASDAQ:RYTM) Posts Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $81.00 - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Rhythm Pharmaceuticals sets annual meeting for June 24 By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 28, 2025

Rhythm Pharmaceuticals sets annual meeting for June 24 - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

Rhythm Pharmaceuticals (NASDAQ:RYTM) Earns Buy Rating from Needham & Company LLC - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

RHYTHM PHARMACEUTICALS, INC. SEC 10-K Report - TradingView

Feb 28, 2025
pulisher
Feb 28, 2025

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Shares Purchased by Rhumbline Advisers - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

Rhythm Pharmaceuticals’ Earnings Call Highlights Growth and Challenges - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Citizens JMP raises Rhythm Pharma stock target to $81 By Investing.com - Investing.com Canada

Feb 27, 2025
pulisher
Feb 27, 2025

State of New Jersey Common Pension Fund D Makes New Investment in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 27, 2025
pulisher
Feb 27, 2025

Canaccord lifts Rhythm Pharma stock target to $81, keeps Buy rating By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

Rhythm Pharmaceuticals: Strong Buy Rating Backed by IMCIVREE’s Growth and Promising Pipeline Developments - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Canaccord lifts Rhythm Pharma stock target to $81, keeps Buy rating - Investing.com UK

Feb 27, 2025
pulisher
Feb 27, 2025

We Think Rhythm Pharmaceuticals (NASDAQ:RYTM) Can Afford To Drive Business Growth - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Rhythm Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Rhythm Pharmaceuticals Inc (RYTM) Q4 2024 Earnings Call Highligh - GuruFocus.com

Feb 27, 2025
pulisher
Feb 27, 2025

Rhythm Pharmaceuticals Reports Strong 2024 Growth and Strategic Advances - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Rhythm Pharmaceuticals Inc (RYTM) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Rhythm Pharmaceuticals: Strong Commercial Execution and Promising Pipeline Drive Buy Rating - TipRanks

Feb 27, 2025
pulisher
Feb 26, 2025

Earnings call transcript: Rhythm Pharmaceuticals Q4 2024 beats earnings forecast - Investing.com

Feb 26, 2025
pulisher
Feb 26, 2025

Rhythm Pharmaceuticals Q4 Loss Widens, Revenue Increases -February 26, 2025 at 07:32 am EST - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings Flash (RYTM) Rhythm Pharmaceuticals Posts Q4 Revenue $41.8M, vs. FactSet Est of $38.5M - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings Flash (RYTM) Rhythm Pharmaceuticals Posts Q4 Net Loss $0.72 a Share, vs. FactSet Est of $0.69 Loss - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update - TradingView

Feb 26, 2025
pulisher
Feb 26, 2025

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business ... - The Bakersfield Californian

Feb 26, 2025
$307.24
price up icon 0.61%
$76.55
price up icon 1.97%
$32.77
price up icon 0.28%
$20.79
price up icon 8.34%
$99.47
price up icon 2.06%
biotechnology ONC
$259.19
price up icon 1.81%
Kapitalisierung:     |  Volumen (24h):